{"id":"https://openalex.org/W2296327233","doi":null,"title":"Celecoxib Treatment Alters p53 and MDM2 Expression via COX-2 Crosstalk in A549 Cells.","display_name":"Celecoxib Treatment Alters p53 and MDM2 Expression via COX-2 Crosstalk in A549 Cells.","publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W2296327233","mag":"2296327233","pmid":"https://pubmed.ncbi.nlm.nih.gov/27642319","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5018276"},"language":"en","primary_location":{"id":"pmid:27642319","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27642319","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iranian journal of pharmaceutical research : IJPR","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5018276/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036021065","display_name":"Mehdi Gharghabi","orcid":"https://orcid.org/0000-0001-8030-3121","observed_orcids":["https://orcid.org/0000-0001-8030-3121"]},"institutions":[{"id":"https://openalex.org/I70640408","display_name":"Tehran University of Medical Sciences","ror":"https://ror.org/01c4pz451","country_code":"IR","type":"education","lineage":["https://openalex.org/I70640408"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Mehdi Gharghabi","raw_affiliation_strings":["Department of Toxicology-Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Toxicology-Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran","institution_ids":["https://openalex.org/I70640408"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056315281","display_name":"Farhang Rezaei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I70640408","display_name":"Tehran University of Medical Sciences","ror":"https://ror.org/01c4pz451","country_code":"IR","type":"education","lineage":["https://openalex.org/I70640408"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Farhang Rezaei","raw_affiliation_strings":["Department of Toxicology-Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Toxicology-Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran","institution_ids":["https://openalex.org/I70640408"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057464134","display_name":"Fereshteh Mir Mohammadrezaei","orcid":"https://orcid.org/0000-0003-1286-7210","observed_orcids":["https://orcid.org/0000-0003-1286-7210"]},"institutions":[{"id":"https://openalex.org/I4871159","display_name":"University of Mazandaran","ror":"https://ror.org/05fp9g671","country_code":"IR","type":"education","lineage":["https://openalex.org/I4871159"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Fereshteh Mir Mohammadrezaei","raw_affiliation_strings":["Department of Biology, Faculty of Science, University of Mazandaran, Mazandaran, Babolsar, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology, Faculty of Science, University of Mazandaran, Mazandaran, Babolsar, Iran","institution_ids":["https://openalex.org/I4871159"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008618632","display_name":"Mohammad Hossein Ghahremani","orcid":"https://orcid.org/0000-0001-5051-6214","observed_orcids":["https://orcid.org/0000-0001-5051-6214"]},"institutions":[{"id":"https://openalex.org/I70640408","display_name":"Tehran University of Medical Sciences","ror":"https://ror.org/01c4pz451","country_code":"IR","type":"education","lineage":["https://openalex.org/I70640408"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Mohammad Hossein Ghahremani","raw_affiliation_strings":["Department of Toxicology-Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Toxicology-Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran","institution_ids":["https://openalex.org/I70640408"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5032,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.67676838,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"15","issue":"2","first_page":"483","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.5386000275611877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.5386000275611877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.45260000228881836,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.9559999704360962},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.9589999914169312},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.8659999966621399},{"id":"https://openalex.org/keywords/mdm2","display_name":"MDM2","score":1.0},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.8569999933242798},{"id":"https://openalex.org/keywords/a549-cells","display_name":"A549 cells","score":0.984000027179718},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.8650000095367432},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.8080000281333923},{"id":"https://openalex.org/keywords/tumor-suppressor-regulation","display_name":"tumor suppressor regulation","score":0.7839999794960022},{"id":"https://openalex.org/keywords/cell-viability","display_name":"cell viability","score":0.5889999866485596}],"concepts":[{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.7371463179588318},{"id":"https://openalex.org/C169822122","wikidata":"https://www.wikidata.org/wiki/Q230187","display_name":"Crosstalk","level":2,"score":0.6310491561889648},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.6012870073318481},{"id":"https://openalex.org/C2776192174","wikidata":"https://www.wikidata.org/wiki/Q18028978","display_name":"Mdm2","level":3,"score":0.600008487701416},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4250923991203308},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3961101472377777},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38908785581588745},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.28923600912094116},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.28764820098876953},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.24695181846618652},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.21393492817878723},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10583502054214478},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.08633503317832947},{"id":"https://openalex.org/C24326235","wikidata":"https://www.wikidata.org/wiki/Q126095","display_name":"Electronic engineering","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"pmid:27642319","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27642319","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iranian journal of pharmaceutical research : IJPR","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5018276","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5018276/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iran J Pharm Res","raw_type":"Text"},{"id":"mag:2296327233","doi":null,"is_oa":false,"landing_page_url":"http://ijpr.sbmu.ac.ir/article_1849_0.html","pdf_url":null,"source":{"id":"https://openalex.org/S54803862","display_name":"Iranian journal of pharmaceutical research","issn_l":"1726-6882","issn":["1726-6882","1726-6890","1735-0328"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319054","host_organization_name":"Shahid Beheshti University","host_organization_lineage":["https://openalex.org/P4310319054"],"host_organization_lineage_names":["Shahid Beheshti University"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Iranian journal of pharmaceutical research","raw_type":null},{"id":"mag:2415609183","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27642319","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:5018276","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5018276/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iran J Pharm Res","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322670","display_name":"Tehran University of Medical Sciences and Health Services","ror":"https://ror.org/01c4pz451"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W12631990","https://openalex.org/W1647640400","https://openalex.org/W1791888878","https://openalex.org/W1815431626","https://openalex.org/W1967257081","https://openalex.org/W1978503888","https://openalex.org/W1986515517","https://openalex.org/W1988397264","https://openalex.org/W1988499106","https://openalex.org/W1996785337","https://openalex.org/W1998394615","https://openalex.org/W2011698701","https://openalex.org/W2027217537","https://openalex.org/W2029397966","https://openalex.org/W2039072661","https://openalex.org/W2050310941","https://openalex.org/W2063530637","https://openalex.org/W2074168286","https://openalex.org/W2077281413","https://openalex.org/W2091487108","https://openalex.org/W2094292688","https://openalex.org/W2099907467","https://openalex.org/W2103261355","https://openalex.org/W2105372476","https://openalex.org/W2111110000","https://openalex.org/W2116787167","https://openalex.org/W2117011972","https://openalex.org/W2136710786","https://openalex.org/W2147753291","https://openalex.org/W2157075616","https://openalex.org/W2168556155","https://openalex.org/W2767686444"],"related_works":["https://openalex.org/W2415609183","https://openalex.org/W2362286921","https://openalex.org/W2394334077","https://openalex.org/W2383741791","https://openalex.org/W126569854","https://openalex.org/W2067788438","https://openalex.org/W2349149571","https://openalex.org/W1993600467","https://openalex.org/W2391764705","https://openalex.org/W1011876433"],"abstract_inverted_index":{"Cyclooxygenase-2":[0],"(COX-2)":[1],"has":[2],"a":[3,23,39,167,192,217],"pivotal":[4],"role":[5,204],"in":[6,61,156,196,205,235],"the":[7,10,20,51,94,107,136,184,206,221,236],"pathogenesis":[8],"of":[9,22,25,32,53,124,208,238],"lung":[11,197,239],"cancer.":[12],"It":[13],"is":[14,35],"known":[15],"that":[16,81,114,186],"COX-2":[17,33,54,125,143,173,211,233],"negatively":[18],"regulates":[19],"activity":[21],"number":[24],"tumor":[26],"suppressors,":[27],"including":[28,210],"p53.":[29],"Consequently,":[30,223],"inhibition":[31,86],"signaling":[34,55,174],"anticipated":[36],"to":[37,42,93,97,101,106,135,201,220,231],"be":[38,191],"promising":[40],"approach":[41],"stabilize":[43],"p53":[44,58,118,134,165],"functionality.":[45],"In":[46,127],"this":[47],"regard,":[48],"we":[49],"investigated":[50],"effect":[52],"blockade":[56],"on":[57],"and":[59,70,212],"COX-2expression":[60],"A549":[62],"cells.":[63],"Cell":[64],"viability":[65,104],"was":[66,73],"assessed":[67],"using":[68,75],"MTT":[69],"protein":[71],"expression":[72,119,144],"measured":[74],"Western":[76,110],"Blot":[77],"assay.":[78],"Results":[79],"revealed":[80],"Celecoxib":[82,115,129,151,177,187],"dose-dependently":[83],"induced":[84,142],"growth":[85],"within":[87,120,145],"24":[88,121],"h.":[89,147,161],"However,":[90],"prolonged":[91],"exposure":[92,152],"drug":[95],"up":[96],"48":[98,146,160],"h":[99],"led":[100],"increase":[102],"cell":[103],"compared":[105],"corresponding":[108],"control.":[109],"blot":[111],"analysis":[112],"demonstrated":[113],"could":[116,153],"augment":[117],"h,":[122],"independently":[123],"inhibition.":[126],"contrast,":[128],"treatment":[130,188,237],"not":[131,190],"only":[132],"returned":[133],"control":[137],"level,":[138],"but":[139],"also":[140],"strikingly":[141],"Of":[148],"further":[149],"relevance,":[150],"significantly":[154],"result":[155],"MDM2":[157,213],"elevation":[158],"at":[159],"These":[162],"findings":[163],"represent":[164],"as":[166],"molecular":[168],"target":[169],"being":[170],"interconnected":[171],"with":[172],"axis":[175],"upon":[176],"treatment.":[178],"Moreover,":[179],"our":[180],"data":[181],"point":[182],"toward":[183],"possibility":[185],"may":[189],"proper":[193],"therapeutic":[194],"strategy":[195],"cancer":[198],"cells":[199],"owing":[200],"its":[202],"potential":[203],"activation":[207],"oncogenes,":[209],"which":[214],"seemingly":[215],"confers":[216],"chemoresistance":[218],"circumstance":[219],"cell.":[222],"these":[224],"results":[225],"underscore":[226],"intensive":[227],"preclinical":[228],"assessment":[229],"prior":[230],"applying":[232],"inhibitors":[234],"tumors.":[240]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}